Chronic myelogenous leukemia secondary to colon cancer: A case report
CML in patients with colon cancer is extremely rare. Secondary hematological tumors may be multifactorial, and the exact mechanism is currently unknown. Owing to the slow progression of the disease, patients with CML show no symptoms in the early stage. However, with disease progression, obvious but non-specific symptoms may appear, including fever, anemia, bleeding tendency, and hypertrophy. Therefore, complete blood count monitoring for routine examination is recommended after cancer treatment for early detection of occult hematological tumors.
Authors
- Juan Tian (ORCID: https://orcid.org/0000-0002-9262-3832)
- Min Li (ORCID: https://orcid.org/0000-0003-1330-2326)
- Zi-Wei Shi
- Hua Yang (ORCID: https://orcid.org/0000-0003-4993-7796)
- Lingzhi Wang (ORCID: https://orcid.org/0000-0001-5585-5426)
- Xiaolan Li (ORCID: https://orcid.org/0000-0001-7426-9983)
- Kui Song (ORCID: https://orcid.org/0000-0001-6296-2369)
Institutions
- Jishou University (CN)
Publication Details
- Journal
- World Journal of Gastrointestinal Oncology
- Published
- 2025-03-24
- DOI
- https://doi.org/10.4251/wjgo.v17.i4.102021
- Primary Topic
- Colorectal Cancer Treatments and Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00